Calculated parenteral initial therapy of bacterial infections: Antibiotic treatment in the elderly.

GMS infectious diseases Pub Date : 2020-03-26 eCollection Date: 2020-01-01 DOI:10.3205/id000049
Peter Walger, Hans Jürgen Heppner
{"title":"Calculated parenteral initial therapy of bacterial infections: Antibiotic treatment in the elderly.","authors":"Peter Walger,&nbsp;Hans Jürgen Heppner","doi":"10.3205/id000049","DOIUrl":null,"url":null,"abstract":"<p><p>This is the fifteenth chapter of the guideline \"Calculated initial parenteral treatment of bacterial infections in adults - update 2018\" in the 2<sup>nd</sup> updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Multimorbidity, an atypical symptomatology of infections in combination with multimedication, the associated interaction risks and serious consequences of synergistic side effects characterize the conditions when deciding on the use of antibiotics in old age. Strict decision regarding the indication itself, choice of the best antibiotic even considering rare side effects which may be dangerous in the elderly, determining the correct dose, dosing interval and the shortest possible duration according to the physiological status of the patient as well as monitoring effectiveness and toxicity detect expected and unexpected side effects early. Recommendations must reflect the peculiarities of antibiotic treatment in elderly patients.</p>","PeriodicalId":91688,"journal":{"name":"GMS infectious diseases","volume":"8 ","pages":"Doc05"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186795/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GMS infectious diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3205/id000049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

This is the fifteenth chapter of the guideline "Calculated initial parenteral treatment of bacterial infections in adults - update 2018" in the 2nd updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. Multimorbidity, an atypical symptomatology of infections in combination with multimedication, the associated interaction risks and serious consequences of synergistic side effects characterize the conditions when deciding on the use of antibiotics in old age. Strict decision regarding the indication itself, choice of the best antibiotic even considering rare side effects which may be dangerous in the elderly, determining the correct dose, dosing interval and the shortest possible duration according to the physiological status of the patient as well as monitoring effectiveness and toxicity detect expected and unexpected side effects early. Recommendations must reflect the peculiarities of antibiotic treatment in elderly patients.

Abstract Image

Abstract Image

Abstract Image

计算细菌感染的肠外初始治疗:老年人的抗生素治疗。
这是指南“计算成人细菌感染的初始肠外治疗-更新2018”的第15章,在第二次更新版本中。由Paul-Ehrlich-Gesellschaft fr chemotherie e.V (PEG)编写的德国指南已被翻译成面向国际受众。多种疾病、感染与多种药物联合的非典型症状、相关的相互作用风险和协同副作用的严重后果是决定在老年人中使用抗生素的条件的特征。严格决定适应症本身,选择最佳抗生素,即使考虑到罕见的副作用,可能对老年人有危险,根据患者的生理状况确定正确的剂量,给药间隔和最短的持续时间,监测疗效和毒性,及早发现预期和意外的副作用。建议必须反映老年患者抗生素治疗的特殊性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信